2009
DOI: 10.1128/jcm.01540-08
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Epidemiology of Candida albicans and Its Closely Related Yeasts Candida dubliniensis and Candida africana

Abstract: We performed a molecular study to determine the occurrence of Candida albicans, Candida africana, and Candida dubliniensis in different clinical samples. The study provides new insights into the epidemiology of candidiasis in hospitalized patients in three hospitals in southern Italy. It also reports the first detailed epidemiological data concerning the occurrence of C. africana in clinical samples.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
39
1
1

Year Published

2009
2009
2017
2017

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 51 publications
(45 citation statements)
references
References 25 publications
4
39
1
1
Order By: Relevance
“…[16]. Pour aboutir à l'identification correcte de cette espèce, nous avons utilisé plusieurs méthodes.…”
Section: Discussionunclassified
“…[16]. Pour aboutir à l'identification correcte de cette espèce, nous avons utilisé plusieurs méthodes.…”
Section: Discussionunclassified
“…However, currently C. africana is known as a biovariant of C. albicans with an exceptional capacity to colonize human genitalia and cause mainly vaginal infections (Romeo and Criseo, 2011; Romeo et al, 2013). Its distribution appears to be worldwide, with cases of infection reported from China (Shan et al, 2014; Hu et al, 2015), Japan (Odds et al, 2007), South Korea (Song et al, 2014), Colombia (Rodríguez-Leguizamón et al, 2015), Argentina (Theill et al, 2016), Chile (Odds et al, 2007), India (Sharma et al, 2014), Iran (Yazdanparast et al, 2015), Africa (Tietz et al, 2001; Dieng et al, 2012; Nnadi et al, 2012; Ngouana et al, 2015), USA (Romeo et al, 2013), and Europe (Alonso-Vargas et al, 2008; Romeo and Criseo, 2009; Borman et al, 2013). However, despite the efforts made so far, it is rather difficult to discriminate C. africana from C. albicans in clinical diagnostic laboratories and therefore its epidemiology is still unclear and needs more investigation (Romeo et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…However, despite the efforts made so far, it is rather difficult to discriminate C. africana from C. albicans in clinical diagnostic laboratories and therefore its epidemiology is still unclear and needs more investigation (Romeo et al, 2013). Nevertheless, overall prevalence of C. africana in European vaginal samples can be estimated around 6–16% (Romeo and Criseo, 2009; Borman et al, 2013) while in Africa, it appears to be much more variable ranging from ∼2% in Senegal and Nigeria to 23% in Angola and 40% in Madagascar (Romeo et al, 2013). …”
Section: Introductionmentioning
confidence: 99%
“…Epidemiological analyses of C. africana have been hampered by the failure of the commonly employed commercially available identification methods to distinguish it from C. albicans (reviewed in references 21 and 16). However, studies employing PCR amplicon length analyses of the Hwp-1 gene (24) revealed that C. africana constituted 7.2% of C. albicans complex isolates in three different hospitals in southern Italy, a prevalence 3 times that of C. dubliniensis in samples from principally nonsterile sites from the same cohort of hospitalized patients (25).…”
Section: T He Incidence Of Invasive Fungal Infections Caused By Unusualmentioning
confidence: 99%